Correlation Between Different Levels of Thyroid Peroxidase Antibody and Postpartum Thyroiditis in Early Pregnancy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

400 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-08-31

Study Completion Date

2020-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

At present, attention to thyroid disease during pregnancy is increasing at home and abroad, but there is relatively little concern about postpartum thyroid disease, especially high incidence of postpartum thyroiditis (PPT). This observational study is to investigate the relationship between different levels of thyroid peroxidase antibody (TPOAb) and postpartum thyroiditis (PPT) in early pregnancy (1-12 weeks of pregnancy), and to explore whether PPT can be predicted by different TPOAb levels. According to the TPOAb level in early pregnancy, the postpartum of pregnant women was followed up, PPT was detected early, and intervention was performed according to thyroid dysfunction.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Screening of Subclinical Hypothyroidism in Pregnant Women

NCT05801822

Subclinical Hypothyroidism

UNKNOWN

The Establish of Specific Reference Ranges for Thyroid Tests in Pregnant Women

NCT02966405

Diseases Pregnancy Thyroid

UNKNOWN

Antithyroidal Antibodies With or Without Subclinical Hypothyroidism During Pregnancy in Infertile Women

NCT04249271

Thyroid Gland Disease Pregnancy Complications

COMPLETED

The Effect of Thyroid Antibodies on Female Reproductive Function and Pregnancy Outcomes

NCT04952012

Thyroiditis, Autoimmune

UNKNOWN

Thyroid Screening Protocol During Pregnancy: a Multi-center Prospective Controlled Study

NCT01838031

Subclinical Hypothyroidism

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

First pregnant women who between the ages of 18 to 35 years old and normal thyroid function before pregnancy were selected. Recruit 300 pregnant women who early pregnancy (1-12 weeks of pregnancy) screening TPOAb positive and normal Free triiodothyronine (FT3), normal free thyroxine (FT4) ,Thyroid Stimulating Hormone (TSH) \<4.78mIU / L as the observation group. They will be divided into low-level group (TPOAb at 34-102 IU/ml), medium-level group (TPOAb at 103-204 IU/ml), and high-level group (TPOAb\>205) according to TPOAb. Recruit 100 pregnant women who early pregnancy (1-12 weeks of pregnancy) screening TPOAb negative and normal FT3, normal FT4,TSH \<4.78mIU / L as the Control group.

Thyroid function (FT3, FT4, TSH) and TPOAb, thyroglobulin antibody(TgAb) ,thyroid hormone receptor antibody(TRAb) will be screened in the observation group and the control group at 3 months, 6 months, and 12 months after delivery. If the mother is diagnosed with postpartum thyroiditis (PPT), continue to screen for thyroid function (FT3, FT4, TSH) and thyroid antibodies (TPOAb, TRAb, TgAb) 18 months after delivery. The correlation between the early pregnancy TPOAb level and postpartum thyroiditis was analyzed between the observation group and the control group and the observation group. It was explored whether the occurrence of postpartum thyroiditis (PPT) can be predicted according to the TPOAb level in the first trimester. And targeted maternal effective follow-up and timely intervention to treat PPT provide important basis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postpartum Thyroiditis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Low level of TPOAb

normal thyroid function (FT3, FT4, TSH) before pregnancy, First pregnancy under 35 years old, early screening (1-12 weeks of pregnancy), initial screening of TPOAb positive, thyroid function: normal FT3 and FT4, TSH\<4.78mIU/L，TPOAb at 34-102 IU/ml.

No interventions assigned to this group

Medium level of TPOAb

normal thyroid function (FT3, FT4, TSH) before pregnancy, First pregnancy under 35 years old, early screening (1-12 weeks of pregnancy), initial screening of TPOAb positive, thyroid function: normal FT3 and FT4, TSH\<4.78mIU/L，TPOAb at 103-204 IU/ml.

No interventions assigned to this group

High level of TPOAb

normal thyroid function (FT3, FT4, TSH) before pregnancy, First pregnancy under 35 years old, early screening (1-12 weeks of pregnancy), initial screening of TPOAb positive, thyroid function: normal FT3 and FT4, TSH\<4.78mIU/L，TPOAb \>205IU/ml.

No interventions assigned to this group

Control group

normal thyroid function (FT3, FT4, TSH) before pregnancy, First pregnancy under 35 years old, early screening (1-12 weeks of pregnancy), initial screening of negative Thyroid antibody, thyroid function: normal FT3 and FT4, TSH\<4.78mIU/L.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Observation group:

* Pre-pregnancy tests for normal thyroid function (FT3, FT4, TSH)
* First pregnancy between the ages of 18 to 35 years old
* Early screening (1-12 weeks of pregnancy) initial screening TPOAb positive，thyroid function FT3, FT4 normal, TSH\<4.78mIU/ L
2. Control group:

* Pre-pregnancy tests for normal thyroid function (FT3, FT4, TSH) and antibodies
* First pregnancy between the ages of 18 to 35 years old
* Early pregnancy (1-12 weeks of pregnancy) initial screening negative thyroid-related antibody and thyroid function FT3, FT4 normal, TSH\< 4.78 mIU/L.

Exclusion Criteria

* Combined with other autoimmune diseases (such as systemic lupus erythematosus, etc.)
* Type 1 diabetes
* Gestational diabetes;
* Primary screening TRAb positive;
* Previous patients with Graves, subacute thyroiditis,chronic hepatitis
* Artificial pregnancy
* Suffering from liver and kidney dysfunction and other major diseases
* Have a history of adverse pregnancy
* Pregnant women with premature birth, miscarriage, intrauterine dysplasia and other unhealthy pregnancies withdrew from observation.

Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes